LinkedInFacebookXYouTube

AI in Clinical Trials

Starting from predictive analytics introduced in 2017, we have continually expanded our AI capabilities. By 2020, we were leveraging Machine Learning for predictive analytics across all clinical research metrics, providing precise and comprehensive insights.

In 2023, we introduced “Ask AI” for clinical risk assessment and AI-augmented regulatory inspections, enabling targeted and efficient risk assessments and regulatory preparations.

In 2024, we launched AI-augmented clinical Due Diligence, further enhancing our suite of AI-driven solutions. This progress has been recognized with Microsoft Healthcare AI Certification in 2025, achieved after a rigorous independent audit, underscoring our commitment to ethical, validated AI in clinical trials.

Oct 2025

MHRA 2025: New Guidance for Medical Device Investigations

By |2025-10-07T13:30:58+02:00October 7, 2025|AI in Clinical Trials, Good Clinical Practice, News|Comments Off on MHRA 2025: New Guidance for Medical Device Investigations

The MHRA’s latest guidance clarifies how medical device investigations are managed across Great Britain and Northern Ireland. Cyntegrity helps manufacturers stay inspection-ready with AI-enhanced RBQM tools that strengthen documentation, risk control, and overall data quality from design through post-market follow-up.

Read More
Sep 2025

World Heart Day 2025: Smarter Heart Trials

By |2025-09-29T15:07:21+02:00September 29, 2025|AI in Clinical Trials, Blog, News|Comments Off on World Heart Day 2025: Smarter Heart Trials

On World Heart Day 2025, Cyntegrity highlights the importance of safer, smarter cardiovascular clinical trials. Using the Heart Failure RACT and Risk-Based Quality Management, we help identify patient risks early, improve trial design, and ensure data quality keeping patient safety at the heart of every study.

Read More
Sep 2025

Clinical Trials and Patient Safety

By |2025-09-23T16:41:43+02:00September 17, 2025|AI in Clinical Trials, Blog, News|Comments Off on Clinical Trials and Patient Safety

Every 17 September, World Patient Safety Day reminds our industry that safety is not just an outcome, it’s a discipline. In clinical research, safety begins long before first-patient-in and continues with every data point captured, every deviation resolved, and every monitoring decision made.

Read More
Jan 2025

Cyntegrity’s MyRBQM Portal: Microsoft-Certified AI in Healthcare

By |2025-01-20T13:36:47+02:00January 20, 2025|AI in Clinical Trials, News|Comments Off on Cyntegrity’s MyRBQM Portal: Microsoft-Certified AI in Healthcare

Cyntegrity’s MyRBQM Portal is the first clinical trial data science software to achieve Microsoft Healthcare AI Certification following a rigorous independent audit. This recognition underscores our commitment to ethical, reliable AI solutions and patient safety. Learn more about this milestone and our AI-driven advancements in clinical trials: Read the full article.

Read More
Oct 2024

Navigating ICH E6(R3): New Standards for Medical Monitoring

By |2024-10-31T10:30:22+02:00October 30, 2024|AI in Clinical Trials, Blog, Good Clinical Practice, News|Comments Off on Navigating ICH E6(R3): New Standards for Medical Monitoring

Preparing for ICH E6(R3)? Discover how medical monitors can adapt to new safety, compliance, and data integrity standards with advanced monitoring tools.

Read More
Sep 2024

EMA Releases New Guidelines for Safe Use of Large Language Models in Regulatory Science

By |2024-09-19T14:22:20+02:00September 19, 2024|AI in Clinical Trials, Good Clinical Practice, News|Comments Off on EMA Releases New Guidelines for Safe Use of Large Language Models in Regulatory Science

The EMA has released key guidelines on the responsible use of large language models (LLMs) in regulatory science. Discover how AI tools like GPT can streamline tasks while addressing privacy and accuracy challenges, and learn about the EMA’s approach to safe and ethical implementation.

Read More
Jun 2024

Responsible AI in Clinical Trials

By |2024-06-10T18:17:25+02:00June 3, 2024|AI in Clinical Trials, Blog, News|Comments Off on Responsible AI in Clinical Trials

Our November 2023 event, “Responsible AI in Clinical Trials,” gathered industry experts and over 160 attendees to discuss AI's future, opportunities, and challenges. Keith Dorricott shares insights from the summit and highlights why you should book for the next one on October 8-9, 2024!

Read More
Mar 2024

Key Takeaways from PHUSE US Connect 2024

By |2024-05-10T17:03:25+02:00March 5, 2024|AI in Clinical Trials, Blog, News|Comments Off on Key Takeaways from PHUSE US Connect 2024

Explore key takeaways from the PHUSE US Connect 2024 conference, highlighting the future of clinical trials, the importance of data integrity, and the role of AI/ML methodologies. Discover how Cyntegrity's vision for QbD and integrated RBQM is shaping the industry.

Read More
Nov 2023

Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

By |2024-05-10T17:00:40+02:00November 2, 2023|AI in Clinical Trials, News|Comments Off on Cyntegrity Hosts Virtual Dialogue on Responsible AI in Clinical Trials

We proudly present our virtual dialogue on Responsible AI in Clinical Trials this November 15 & 16, uniting industry and academic experts for groundbreaking discussions and insights.

Read More
May 2020

AI-Enhanced Machine Learning Predictions for All Clinical Research Metrics

By |2024-05-10T17:02:08+02:00May 27, 2020|AI in Clinical Trials, Neat Features, News|Comments Off on AI-Enhanced Machine Learning Predictions for All Clinical Research Metrics

MyRBQM® Portal's new Machine Learning predictive analytics model is far less sensitive to noise, it better generalizes data, and provides narrower CIs in long time series. Singular Spectrum Analysis is particularly valuable for long time series, as mostly observed in clinical trials.

Read More
Go to Top